the future of childhood brain cancer is bright

Last week, Children’s Cancer Institute hosted the world’s premier conference on paediatric brain tumour research — the International Symposium on Paediatric Neuro-Oncology (ISPNO 2026) — bringing together almost 1,000 delegates from 56 countries to share discoveries that could shape the next generation of treatments.

Children’s Cancer Institute were centre stage at this prestigious international event. Professor David Ziegler, head of Levi’s Project, was the Chair of ISPNO 2026. Associate Professor Maria Tsoli, the Levi Wheeler Fellow, and Dr Aaminah Khan from the Brain Tumours Group, were both on the organising team and led panels. They were joined by many other outstanding @childrenscancerinstitute researchers who were instrumental in bringing the world's leading clinicians, scientists and researchers together to exchange ideas, forge collaborations and accelerate progress for children with brain cancer.

The science was nothing short of inspiring. For the first time in ISPNO’s history, there were two dedicated scientific sessions focused solely on DIPG/DMG — a reflection of the incredible momentum building in the field. More than 160 abstracts were submitted on these devastating tumours alone.

Children’s Cancer Institute and their collaborators contributed 10 scientific posters, presented the latest findings from Levi’s CATCH, chaired major scientific sessions and joined the world’s foremost experts discussing everything from tumour biology and immunotherapy to novel therapeutics, biomarkers and clinical trials.

This is exactly why Levi’s Project exists ⬇️

🧠To back the people asking the biggest questions
💥To accelerate the discoveries that change outcomes
👊 To ensure Australia continues to lead on the world stage in the fight against DIPG

We couldn’t be prouder to stand behind Children’s Cancer Institute as they continue to push the boundaries of what’s possible for children diagnosed with DIPG.